Checkpoint Therapeutics Inc (CKPT)
3.76
+0.15
(+4.16%)
USD |
NASDAQ |
Nov 14, 16:00
3.76
0.00 (0.00%)
After-Hours: 17:38
Checkpoint Therapeutics Enterprise Value: 157.56M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 157.56M |
| November 12, 2024 | 150.36M |
| November 11, 2024 | 138.66M |
| November 08, 2024 | 146.76M |
| November 07, 2024 | 150.81M |
| November 06, 2024 | 146.76M |
| November 05, 2024 | 143.61M |
| November 04, 2024 | 152.16M |
| November 01, 2024 | 153.06M |
| October 31, 2024 | 149.91M |
| October 30, 2024 | 158.01M |
| October 29, 2024 | 167.92M |
| October 28, 2024 | 160.71M |
| October 25, 2024 | 160.26M |
| October 24, 2024 | 149.91M |
| October 23, 2024 | 148.56M |
| October 22, 2024 | 137.31M |
| October 21, 2024 | 138.21M |
| October 18, 2024 | 130.55M |
| October 17, 2024 | 128.75M |
| October 16, 2024 | 122.00M |
| October 15, 2024 | 113.90M |
| October 14, 2024 | 109.17M |
| October 11, 2024 | 104.67M |
| October 10, 2024 | 101.74M |
| Date | Value |
|---|---|
| October 09, 2024 | 100.39M |
| October 08, 2024 | 101.74M |
| October 07, 2024 | 104.89M |
| October 04, 2024 | 94.99M |
| October 03, 2024 | 93.19M |
| October 02, 2024 | 95.89M |
| October 01, 2024 | 93.64M |
| September 30, 2024 | 95.89M |
| September 27, 2024 | 96.34M |
| September 26, 2024 | 95.44M |
| September 25, 2024 | 95.89M |
| September 24, 2024 | 94.99M |
| September 23, 2024 | 101.29M |
| September 20, 2024 | 103.54M |
| September 19, 2024 | 104.44M |
| September 18, 2024 | 105.79M |
| September 17, 2024 | 108.49M |
| September 16, 2024 | 100.39M |
| September 13, 2024 | 98.59M |
| September 12, 2024 | 93.86M |
| September 11, 2024 | 94.54M |
| September 10, 2024 | 91.39M |
| September 09, 2024 | 90.94M |
| September 06, 2024 | 89.59M |
| September 05, 2024 | 91.84M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
14.03M
Minimum
Dec 08 2022
313.42M
Maximum
Nov 09 2021
97.43M
Average
80.72M
Median
Oct 05 2022
Enterprise Value Benchmarks
| Fortress Biotech Inc | -1.023M |
| Avenue Therapeutics Inc | -3.065M |
| Journey Medical Corp | 102.58M |
| NovaBay Pharmaceuticals Inc | 3.432M |
| Palatin Technologies Inc | 13.74M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.67M |
| Revenue (Quarterly) | 0.041M |
| Total Expenses (Quarterly) | 6.714M |
| EPS Diluted (Quarterly) | -0.18 |
| Profit Margin (Quarterly) | -16.27K% |
| Earnings Yield | -50.53% |
| Normalized Earnings Yield | -44.47 |